Regina W. Wang

2.4k total citations
32 papers, 1.9k citations indexed

About

Regina W. Wang is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Regina W. Wang has authored 32 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Regina W. Wang's work include Pharmacogenetics and Drug Metabolism (22 papers), Drug Transport and Resistance Mechanisms (14 papers) and Inflammatory mediators and NSAID effects (4 papers). Regina W. Wang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (22 papers), Drug Transport and Resistance Mechanisms (14 papers) and Inflammatory mediators and NSAID effects (4 papers). Regina W. Wang collaborates with scholars based in United States, Japan and Canada. Regina W. Wang's co-authors include Anthony Y.H. Lu, Deborah J. Newton, William M. Atkins, Wei Tang, Thomas A. Baillie, Ralph A. Stearns, Kui Cheng, Nini Liu, Kenan Qin and Marilyn Khanna and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Regina W. Wang

32 papers receiving 1.8k citations

Peers

Regina W. Wang
S. Ball United States
Toshiro Niwa Japan
Jean‐Charles Gautier France
Cuyue Tang United States
David R. Jones United States
Deborah J. Newton United States
Donald Tweedie United States
Kamlesh P. Vyas United States
Wei Tang United States
Liang‐Shang Gan United States
S. Ball United States
Regina W. Wang
Citations per year, relative to Regina W. Wang Regina W. Wang (= 1×) peers S. Ball

Countries citing papers authored by Regina W. Wang

Since Specialization
Citations

This map shows the geographic impact of Regina W. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regina W. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regina W. Wang more than expected).

Fields of papers citing papers by Regina W. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Regina W. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regina W. Wang. The network helps show where Regina W. Wang may publish in the future.

Co-authorship network of co-authors of Regina W. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Regina W. Wang. A scholar is included among the top collaborators of Regina W. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Regina W. Wang. Regina W. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grimm, Scott, Heidi J. Einolf, Kan He, et al.. (2009). The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America. Drug Metabolism and Disposition. 37(7). 1355–1370. 224 indexed citations
2.
Krishna, Rajesh, Arthur Bergman, Bo Jin, et al.. (2008). Assessment of the CYP3A‐Mediated Drug Interaction Potential of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Volunteers. The Journal of Clinical Pharmacology. 49(1). 80–87. 31 indexed citations
3.
Chu, Xiaoyan, John R. Strauss, Jing Li, et al.. (2006). Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2). Journal of Pharmacology and Experimental Therapeutics. 317(2). 579–589. 105 indexed citations
4.
Tang, Wei, Regina W. Wang, & Anthony Y.H. Lu. (2005). Utility of Recombinant Cytochrome P450 Enzymes: A Drug Metabolism Perspective. Current Drug Metabolism. 6(5). 503–517. 28 indexed citations
5.
Newton, Deborah J., Regina W. Wang, & David C. Evans. (2005). Determination of phase I metabolic enzyme activities in liver microsomes of Mrp2 deficient TR− and EHBR rats. Life Sciences. 77(10). 1106–1115. 14 indexed citations
6.
Chen, Qing, George A. Doss, Yui S. Tang, et al.. (2005). EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS. Drug Metabolism and Disposition. 34(1). 145–151. 38 indexed citations
7.
Wang, Regina W., et al.. (2004). Coimmunoprecipitation of UDP-Glucuronosyltransferase Isoforms and Cytochrome P450 3A4. Molecular Pharmacology. 67(1). 260–262. 42 indexed citations
8.
Sánchez, Rosa I., Regina W. Wang, Deborah J. Newton, et al.. (2004). CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT. Drug Metabolism and Disposition. 32(11). 1287–1292. 101 indexed citations
9.
Kumar, Sanjeev, Gloria Y. Kwei, Grace K. Poon, et al.. (2003). Pharmacokinetics and Interactions of a Novel Antagonist of Chemokine Receptor 5 (CCR5) with Ritonavir in Rats and Monkeys: Role of CYP3A and P-Glycoprotein. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1161–1171. 19 indexed citations
10.
Lu, Anthony Y.H., Regina W. Wang, & Jiunn H. Lin. (2003). Cytochrome P450 In Vitro Reaction Phenotyping: A Re-evaluation of Approaches Used for P450 Isoform Identification. Drug Metabolism and Disposition. 31(4). 345–350. 68 indexed citations
11.
Wang, Regina W., et al.. (1997). Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis.. PubMed. 25(4). 502–7. 135 indexed citations
12.
Dietze, Eric C., Regina W. Wang, Anthony Y.H. Lu, & William M. Atkins. (1996). Ligand Effects on the Fluorescence Properties of Tyrosine-9 in Alpha 1-1 Glutathione S-Transferase. Biochemistry. 35(21). 6745–6753. 25 indexed citations
13.
Khanna, Marilyn, Kenan Qin, Regina W. Wang, & Kui Cheng. (1995). Substrate Specificity, Gene Structure, and Tissue-specific Distribution of Multiple Human 3α-Hydroxysteroid Dehydrogenases. Journal of Biological Chemistry. 270(34). 20162–20168. 161 indexed citations
14.
Wang, Regina W., Deborah J. Newton, Cecil B. Pickett, & Anthony Y.H. Lu. (1992). Site-directed mutagenesis of glutathione S-transferase YaYa: Functional studies of histidine, cysteine, and tryptophan mutants. Archives of Biochemistry and Biophysics. 297(1). 86–91. 17 indexed citations
15.
Wang, Regina W., Deborah J. Newton, Cecil B. Pickett, & Anthony Y.H. Lu. (1991). Site-directed mutagenesis of glutathione S-transferase YaYa: Nonessential role of histidine in catalysis. Archives of Biochemistry and Biophysics. 286(2). 574–578. 24 indexed citations
16.
Vincent, Styliani H., et al.. (1991). Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase. Biochemical Pharmacology. 41(9). 1325–1330. 6 indexed citations
17.
Vyas, Kamlesh P., Prasad H. Kari, Regina W. Wang, & Anthony Y.H. Lu. (1990). Biotransformation of lovastatin—III. Biochemical Pharmacology. 39(1). 67–73. 15 indexed citations
18.
Wang, Regina W., et al.. (1988). In vitro studies on the interaction of famotidine with liver microsomal cytochrome P-450. Biochemical Pharmacology. 37(15). 3049–3053. 7 indexed citations
19.
Lu, Anthony Y.H., Peter G. Wislocki, Edward S. Bagan, et al.. (1984). Mechanism of metabolic activation of ronidazole, a 5-nitroimidazole. Biochemical Society Transactions. 12(1). 7–9. 1 indexed citations
20.
Thiele, Dennis J., Regina W. Wang, & Michael J. Leibowitz. (1982). Separation and sequence of the 3′ termini of M double-stranded RNA from killer yeast. Nucleic Acids Research. 10(5). 1661–1678. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Ball Breakdown of academic impact, for papers by Toshiro Niwa Breakdown of academic impact, for papers by Jean‐Charles Gautier Breakdown of academic impact, for papers by Cuyue Tang Breakdown of academic impact, for papers by David R. Jones Breakdown of academic impact, for papers by Deborah J. Newton Breakdown of academic impact, for papers by Donald Tweedie Breakdown of academic impact, for papers by Kamlesh P. Vyas Breakdown of academic impact, for papers by Wei Tang Breakdown of academic impact, for papers by Liang‐Shang Gan
Rankless by CCL
2026